Martin, S., Blair, E., Sexton, S., Bhushan, K., Cavanaugh, K., McManus, J., Spidle, J., Vo, K. T., Foster, J. H., Bagatell, R., Balis, F. M., Crompton, B. D., Shusterman, S., London, W. B., DuBois, S. G. (2026). Feasibility study of prolonged administration of naxitamab, irinotecan, and temozolomide for patients with relapsed or refractory neuroblastoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps10058